Streptomyces extracellular vesicles are a broad and permissive antimicrobial packaging and delivery system
Abstract
Streptomyces are the primary source of bioactive specialized metabolites used in research and medicine, including many antimicrobials. These are presumed to be secreted and function as freely soluble compounds. However, increasing evidence suggests extracellular vesicles are an alternative secretion system. We assessed environmental and lab-adapted Streptomyces (sporulating filamentous actinomycetes) and found a majority of strains produce vesicles packaging antimicrobial compounds. The cargo included actinomycins, anthracyclines, candicidin, and actinorhodin, reflecting both diverse chemical properties and diverse antibacterial and antifungal activity. The production of the antimicrobials and vesicles was linked, although vesicle production continued in the absence of antimicrobials. We demonstrated that antimicrobial-containing vesicles achieve direct delivery of the cargo to other microbes. Notably, this delivery via membrane fusion occurred to a broad range of microbes including pathogenic bacteria and yeast. Vesicle encapsulation offers a broad and permissive packaging and delivery system for antimicrobial specialized metabolites, with important implications for ecology and translation. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=185 SRC="FIGDIR/small/560488v1_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@56f1c6org.highwire.dtl.DTLVardef@1b33aeorg.highwire.dtl.DTLVardef@1ddf706org.highwire.dtl.DTLVardef@184e75e_HPS_FORMAT_FIGEXP M_FIG C_FIG IMPORTANCEExtracellular vesicle encapsulation changes our picture of how antimicrobial metabolites function in the environment, and provides an alternative translational approach for delivery of antimicrobials. We find the majority of Streptomyces strains are capable of releasing antimicrobial vesicles, and at least four distinct classes of compounds can be packaged, suggesting this is widespread in nature. This is a striking departure from the primary paradigm of secretion and action of specialized metabolites as soluble compounds. Importantly the vesicles deliver antimicrobial metabolites directly to other microbes via membrane fusion, including to pathogenic bacteria and yeast. This suggests future applications in which lipid-encapsulated natural product antibiotics and antifungals could be used to solve some of the most pressing problems in drug resistance.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Extracellular vesicle packaging of a supercluster-encoded antimicrobial combination with enhanced potency against fungal biofilms
Kirsten J. Meyer, Valerie Chow, … Justin Rea Nodwell·bioRxiv·Oct 26, 2026
- Production of glycine-derived ammonia as a low-cost and long-distance antibiotic strategy by Streptomyces
M. Avalos, P. Garbeva, … G. P. van Wezel·bioRxiv·Oct 24, 2018
- The biogenesis of extracellular vesicles from Staphylococcus aureus and their application as a novel vaccine platform
X. Wang, C. Weidenmaier, J. C. Lee·bioRxiv·Jan 28, 2018
- Environmental cues shape extracellular vesicles biogenesis and function in Streptococcus pneumoniae
Miriana Battista, Yann Bachelot, … Cláudia Vilhena·BMC MicrobiologyPeer-reviewed·Mar 4, 2026
- Micro-encapsulation extends mycelial viability of Streptomyces lividans 66 and increases enzyme production
B. Zacchetti, A. Andrianos, … D. Claessen·bioRxiv·Oct 17, 2017
- Direct fluorescence detection and volume electron microscopy reveal a role for antibiotic biosynthesis in the bacterial cell envelope of Streptomyces sp. Mg1
Nityakalyani Josyula, Anton Classen, … Paul D. Straight·bioRxiv·Jun 26, 2026